Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21711 | 25102800 | Acta Dermatovenerol Croat | The linkage between psoriasis and non-alcoholic fatty liver disease: a literature review. | 2014 | Details |
| A21718 | 25097051 | Arab J Gastroenterol | Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt. | 2014 | Details |
| A21722 | 25091195 | J Gastroenterol Hepatol | Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders. | 2015 | Details |
| A21727 | 25088269 | Curr Pediatr Rev | Nonalcoholic fatty liver disease in children: recent practice guidelines, where do they take us? | 2014 | Details |
| A21729 | 25086727 | J Surg Res | Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease. | 2014 | Details |
| A21731 | 25085644 | Am J Kidney Dis | CKD and nonalcoholic fatty liver disease. | 2014 | Details |
| A21734 | 25083081 | World J Gastroenterol | Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease. | 2014 | Details |
| A21735 | 25083080 | World J Gastroenterol | Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? | 2014 | Details |
| A21736 | 25083079 | World J Gastroenterol | Nonalcoholic fatty liver disease and the heart in children and adolescents. | 2014 | Details |
| A21743 | 25075578 | Braz J Med Biol Res | Effect of physical training on liver expression of activin A and follistatin in a nonalcoholic fatty liver disease model in rats. | 2014 | Details |
| A21746 | 25073966 | Pediatr Obes | The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children. | 2014 | Details |
| A21753 | 25071327 | World J Gastroenterol | Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. | 2014 | Details |
| A21755 | 25069836 | Eat Weight Disord | The therapy of insulin resistance in other diseases besides type 2 diabetes. | 2014 | Details |
| A21758 | 25066281 | Liver Int | Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice. | 2014 | Details |
| A21770 | 25059108 | Obes Rev | Metabolically healthy and unhealthy obese--the 2013 Stock Conference report. | 2014 | Details |
| A21777 | 25051240 | Metab Syndr Relat Disord | Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome. | 2014 | Details |
| A21779 | 25050550 | PLoS Med | Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. | 2014 | Details |
| A21783 | 25047370 | Wien Med Wochenschr | Intracellular lipid accumulation and shift during diabetes progression. | 2014 | Details |
| A21784 | 29159094 | J Clin Transl Endocrinol | The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A21787 | 25045276 | Clin Exp Gastroenterol | Molecular pathways in non-alcoholic fatty liver disease. | 2014 | Details |
| A21798 | 25038727 | Metabolism | Metabolically healthy obesity from childhood to adulthood - Does weight status alone matter? | 2014 | Details |
| A21800 | 25035929 | Biochem Biophys Res Commun | PKCδ regulates hepatic triglyceride accumulation and insulin signaling in Lepr(db/db) mice. | 2014 | Details |
| A21801 | 25035342 | Arterioscler Thromb Vasc Biol | Links between ectopic fat and vascular disease in humans. | 2014 | Details |
| A21803 | 25034292 | Dig Dis | Non-alcoholic fatty liver disease: diagnosis and investigation. | 2014 | Details |
| A21811 | 25030027 | BMC Complement Altern Med | Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity. | 2014 | Details |
| A21814 | 25028077 | Transl Res | Obesity and the liver: nonalcoholic fatty liver disease. | 2014 | Details |
| A21816 | 25024624 | World J Gastroenterol | Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation. | 2014 | Details |
| A21817 | 25024607 | World J Gastroenterol | High fat diet feeding results in gender specific steatohepatitis and inflammasome activation. | 2014 | Details |
| A21818 | 25024598 | World J Gastroenterol | Nonalcoholic fatty liver disease and cardiovascular disease. | 2014 | Details |
| A21821 | 25024595 | World J Gastroenterol | Experimental models of non-alcoholic fatty liver disease in rats. | 2014 | Details |
| A21822 | 25024594 | World J Gastroenterol | Nonalcoholic fatty liver disease and polycystic ovary syndrome. | 2014 | Details |
| A21823 | 25024593 | World J Gastroenterol | Modern approach to the clinical management of non-alcoholic fatty liver disease. | 2014 | Details |
| A21824 | 25024592 | World J Gastroenterol | Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis. | 2014 | Details |
| A21826 | 25023045 | Indian J Gastroenterol | Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh. | 2014 | Details |
| A21828 | 25019654 | Gen Comp Endocrinol | The effect of recombinant adeno-associated virus-adiponectin (rAAV2/1-Acrp30) on glycolipid dysmetabolism and liver morphology in diabetic rats. | 2014 | Details |
| A21841 | 25009382 | World J Gastroenterol | Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review. | 2014 | Details |
| A21842 | 25008241 | Mol Cell Endocrinol | Role of aquaglyceroporins and caveolins in energy and metabolic homeostasis. | 2014 | Details |
| A21848 | 25003670 | Turk J Gastroenterol | Nonalcoholic fatty liver disease: diagnosis, pathogenesis, and management. | 2014 | Details |
| A21854 | 24998389 | Sci Rep | Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model. | 2014 | Details |
| A21855 | 24997826 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | Effect of piglitazone and metformin on retinol-binding protein-4 and adiponectin in patients with type 2 diabetes mellitus complicated with non-alcohol fatty acid liver diseases. | 2014 | Details |
| A21857 | 24995693 | Hepatology | The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice. | 2014 | Details |
| A21858 | 24994581 | Panminerva Med | Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease. | 2014 | Details |
| A21864 | 24990583 | Scand J Gastroenterol | Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD. | 2014 | Details |
| A21876 | 24986741 | J Transl Med | Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice. | 2014 | Details |
| A21885 | 24977111 | Curr Hepatol Rep | Hepatic steatosis and steatohepatitis: Are they really two distinct entities? | 2014 | Details |
| A21891 | 24976401 | Biochem Biophys Res Commun | NHE1 deficiency in liver: implications for non-alcoholic fatty liver disease. | 2014 | Details |
| A21895 | 24975463 | Diabet Med | Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India. | 2014 | Details |
| A21898 | 24974878 | Ann Gastroenterol | Insulin resistance in euglycemic cirrhosis. | 2014 | Details |
| A21899 | 24974489 | J Assoc Physicians India | Hepatocyte growth factor, adiponectin and hepatic histopathology in non-alcoholic steatohepatitis. | 2013 | Details |
| A21906 | 24968846 | Nan Fang Yi Ke Da Xue Xue Bao | [Therapeutic effect of saxagliptin in rat models of nonalcoholic fatty liver and type 2 diabetes]. | 2014 | Details |
| A21908 | 24968737 | Endocrine | Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. | 2014 | Details |
| A21909 | 24968200 | Br J Nutr | Beneficial effects of soluble dietary Jerusalem artichoke (Helianthus tuberosus) in the prevention of the onset of type 2 diabetes and non-alcoholic fatty liver disease in high-fructose diet-fed rats. | 2014 | Details |
| A21914 | 24966606 | World J Gastroenterol | Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease. | 2014 | Details |
| A21915 | 24966605 | World J Gastroenterol | Pediatric fatty liver disease: role of ethnicity and genetics. | 2014 | Details |
| A21916 | 24966604 | World J Gastroenterol | Mediterranean diet and non-alcoholic fatty liver disease: new therapeutic option around the corner? | 2014 | Details |
| A21917 | 24966603 | World J Gastroenterol | Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue. | 2014 | Details |
| A21920 | 24966582 | World J Gastroenterol | Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen. | 2014 | Details |
| A21924 | 24962805 | Diabetes Obes Metab | Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis. | 2014 | Details |
| A21926 | 24961681 | Pediatr Obes | Oral fructose absorption in obese children with non-alcoholic fatty liver disease. | 2014 | Details |
| A21930 | 24958099 | Mol Cell Biol | Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. | 2014 | Details |
| A21931 | 24957697 | Scand J Gastroenterol | Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21937 | 24952996 | Neurogastroenterol Motil | Damage to enteric neurons occurs in mice that develop fatty liver disease but not diabetes in response to a high-fat diet. | 2014 | Details |
| A21948 | 24944898 | Mol Metab | Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes. | 2014 | Details |
| A21953 | 24939737 | Am J Physiol Endocrinol Metab | Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract. | 2014 | Details |
| A21957 | 24934631 | Eur J Pediatr | Association between nocturnal blood pressure dipping and insulin resistance in children affected by NAFLD. | 2014 | Details |
| A21964 | 24927647 | J Diabetes Complications | Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease. | 2014 | Details |
| A21969 | 24924900 | Clin Res Hepatol Gastroenterol | Burn after feeding. An old uncoupler of oxidative phosphorylation is redesigned for the treatment of nonalcoholic fatty liver disease. | 2014 | Details |
| A21979 | 24918580 | PLoS One | Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice. | 2014 | Details |
| A21980 | 24917551 | Gut | Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. | 2014 | Details |
| A21981 | 24917523 | Hepatology | Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. | 2014 | Details |
| A21985 | 24913270 | Vet Pathol | The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2014 | Details |
| A21990 | 24906975 | J Endocrinol Invest | Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women. | 2014 | Details |
| A22003 | 24899308 | Nature | The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. | 2014 | Details |
| A22016 | 24887549 | Int J Biol Macromol | Hypoglycemic and hepatoprotective effects of polysaccharides from Artemisia sphaerocephala Krasch seeds. | 2014 | Details |
| A22038 | 24858832 | PLoS One | β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice. | 2014 | Details |
| A22045 | 24853141 | PLoS One | HCC development is associated to peripheral insulin resistance in a mouse model of NASH. | 2014 | Details |
| A22048 | 24851523 | Trop Gastroenterol | Profile of patients with incidentally detected nonalcoholic fatty liver disease (IDNAFLD) in coastal eastern India. | 2014 | Details |
| A22049 | 24850609 | Georgian Med News | [Effect of gene polymorphism of PPARgamma2 regulatory proteins on the metabolic syndrome in children with nonalcoholic fatty liver disease and obesity]. | 2014 | Details |
| A22063 | 24845056 | Hepatology | Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation. | 2014 | Details |
| A22064 | 24844310 | Eat Weight Disord | Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children? | 2014 | Details |
| A22067 | 24843703 | J Diabetes Investig | Role of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver disease. | 2013 | Details |
| A22068 | 24843689 | J Diabetes Investig | Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines. | 2013 | Details |
| A22069 | 24842304 | J Hepatol | Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia. | 2014 | Details |
| A22071 | 24841950 | Obes Surg | The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. | 2014 | Details |
| A22083 | 24830559 | Int J Mol Sci | Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. | 2014 | Details |
| A22084 | 24829925 | J Diabetes Res | Ketosis onset type 2 diabetes had better islet β-cell function and more serious insulin resistance. | 2014 | Details |
| A22088 | 24829682 | Middle East J Dig Dis | Probiotics and Nonalcoholic Fatty liver Disease. | 2013 | Details |
| A22089 | 24829591 | Hepat Mon | Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming". | 2014 | Details |
| A22091 | 24828988 | Eur J Clin Invest | Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance. | 2014 | Details |
| A22096 | 24824123 | Zhonghua Gan Zang Bing Za Zhi | [Relationship of non-alcoholic steatohepatitis with arterial endothelial function and atherosclerosis]. | 2014 | Details |
| A22102 | 24819989 | Steroids | Bile acids are nutrient signaling hormones. | 2014 | Details |
| A22103 | 24819229 | Metab Syndr Relat Disord | Interrelationships of serum androgens, omental adipose tissue metabolism, and nonalcoholic fatty liver disease in obese premenopausal women. | 2014 | Details |
| A22104 | 24818764 | Gastroenterology | No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial. | 2014 | Details |
| A22106 | 24816727 | J Physiol Biochem | Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion. | 2014 | Details |
| A22107 | 24816278 | PLoS One | Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model. | 2014 | Details |
| A22111 | 24814684 | Metabolism | De novo lipogenesis in health and disease. | 2014 | Details |
| A22114 | 24811405 | Appl Microbiol Biotechnol | Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice. | 2014 | Details |
| A22115 | 24806753 | Hepatology | FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis. | 2014 | Details |
| A22118 | 24803810 | World J Gastroenterol | NAFLD prevalence differs among hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis. | 2014 | Details |
| A22121 | 24799990 | World J Hepatol | Pediatric non-alcoholic fatty liver disease: New insights and future directions. | 2014 | Details |